Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
96 hedge funds and large institutions have $97.5M invested in Surgalign Holdings, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 24 increasing their positions, 29 reducing their positions, and 11 closing their positions.
83% more call options, than puts
Call options by funds: $128K | Put options by funds: $70K
64% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 11
24% more capital invested
Capital invested by funds: $78.6M → $97.5M (+$18.9M)
8% more funds holding
Funds holding: 89 → 96 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$1.63M |
| 2 |
TC
TownSquare Capital
Provo,
Utah
|
+$1.4M |
| 3 |
DI
DFPG Investments
Sandy,
Utah
|
+$1.37M |
| 4 |
AC
Armistice Capital
New York
|
+$948K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$459K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Blackstone Inc
New York
|
-$1.35M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$583K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$482K |
| 4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$411K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$330K |
SRGA Hedge Fund Activity: Q4 2020 in Review
96 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q4 2020, worth a combined $97.5M — up 24% from $78.6M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new SRGA positions and 11 closed out — a net gain of 7 holders — while 24 added to existing stakes and 29 trimmed.
The largest buyer was Archon Capital Management, opening a new position worth an estimated $1.63M. The largest seller was Blackstone Inc, exiting entirely with an estimated $1.35M sold.
- 96 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q4 2020, up from 89 in Q3 2020.
- Funds reported $97.5M of Surgalign Holdings, Inc. Common Stock stock for Q4 2020, up 24% quarter-over-quarter.
- 18 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q4 2020 and 11 closed out, a net change of +7 holders.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q4 2020 was Archon Capital Management, an estimated $1.63M added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q4 2020 was Blackstone Inc, an estimated $1.35M sold.
Based on aggregated 13F filings for Q4 2020.